| Annual and Long Service Leave Guidelines
|
SESLHDGL/067 |
|
| Annual Leave and Excessive Annual Leave (EAL) Management
|
SESLHDPR/436 |
|
| Authority to use the NSW Government Waratah and SESLHD Logo
|
SESLHDPR/227 |
|
| Laser Safety - managing the hazards
|
SESLHDPR/162 |
|
| Learning and Development Leave Procedure
|
SESLHDPR/430 |
|
| Leech Therapy (Medicinal)
|
SESLHDGL/035 |
|
| Legislative Compliance Framework
|
SESLHDHB/025 |
|
| Levosimendan
|
SESLHDPR/725 |
|
| Lidocaine (lignocaine) patch for symptomatic treatment of neuropathic pain refractory or unsuitable for alternative medications
|
SESLHDPR/648 |
|
| Lumbar Puncture - Adult
|
SESLHDPR/613 |
|
| Sick Leave Management
|
SESLHDPR/412 |
|
| Staff Specialists and Visiting Practitioners - Facility Fees / Licence to Occupy Charges
|
SESLHDPR/429 |
|
| Sterilisation: Reusable Medical Devices (RMDs) on Loan
|
SESLHDPR/249 |
Under Review |
| Subcutaneous levetiracetam for seizure management in palliative care patients
|
SESLHDPR/692 |
|
| Subcutaneous levomepromazine for refractory nausea in the palliative care patient and agitation in the terminal phase
|
SESLHDPR/693 |
|
| Subcutaneous lidocaine (lignocaine) for refractory neuropathic pain in the palliative care setting
|
SESLHDPR/694 |
|
| Systemic review of clinical practice or lookback process for clinicians of concern
|
SESLHDPR/746 |
|
| Water Systems: Legionella Control in Hospitals
|
SESLHDPR/344 |
|
| Work Health and Safety - Lift Entrapment Emergency Procedure
|
SESLHDPR/715 |
|
